Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2025-12-25 @ 1:12 AM
NCT ID: NCT03008993
Eligibility Criteria: Inclusion Criteria: * Age \> 18 * Diagnosis (histological or cytological) of solid tumor communicated to the patient within the previous two months * About to start a new medical cancer treatment: chemotherapy (IV or oral), molecular target drugs, hormonal therapy, immunotherapy * Expected survival \> 3 months * Good comprehension of the Italian language * Who have read, understood, and signed the informed consent. Exclusion Criteria: * Previous chemotherapy or other medical cancer treatment * Recruited in a previous epoch of the study (that is, patients can only participate during one epoch) * Currently participating in other trials which imply the completion of Patient Reported Outcomes (PROs) in the same period * Hospitalized * Currently receiving psychiatric treatment * Affected by mental or psychiatric disorders, due to cancer or coexisting illness, which interfere with the state of consciousness or impede judgment * Inability to complete the questionnaire or ensure participation in the three-month follow-up
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT03008993
Study Brief:
Protocol Section: NCT03008993